Press Release

CDC approves Novavax; first protein-based COVID-19 vaccine

STATEWIDE (July 19, 2022) — Today, Centers for Disease Control and Prevention (CDC) gave final approval for use of the Novavax COVID-19 vaccine in adults aged 18 and older, as a two-dose primary COVID-19 vaccine series with the two doses separated by three weeks. This announcement followed the CDC’s Advisory Committee on Immunization Practices’ unanimous recommendation and FDA’s approval of emergency use authorization for the vaccine.

CDPHE to update public COVID-19 outbreak data to reflect current stage of response

As the state continues to implement Colorado’s “Roadmap to Moving Forward,” the state’s plan for returning to normalcy, the Colorado Department of Public Health and Environment will transition the public display of its COVID-19 outbreak data to a model aligned with other respiratory pathogens, like influenza.